SOURCE: Creative Edge Nutrition, Inc.

April 23, 2015 22:19 ET

Letter to Shareholders Regarding Emails Released

BEVERLY HILLS, CA and LAKESHORE, ON--(Marketwired - Apr 23, 2015) - Creative Edge Nutrition, Inc. (OTC PINK: FITX), a nutritional supplement company focusing on active lifestyles, announces a letter to its shareholders and email.

Dear Shareholders,

The following is the second installment of documents promised for release in its April 8, 2015 press release. These material documents represent CEN Biotech's communications with Health Canada as early as November 2013, and illustrate the urgency with which Health Canada requested that the facility build out proceed at a faster pace so that an inspection could be scheduled as soon as possible. The documents in turn indicate CEN Biotech's acquiescence with the request to build as fast as possible and the financial detriment incurred as a result of CEN Biotech's reliance on Health Canada's promise of an inspection to be conducted as soon as possible.

Health Canada issues a Ready to Build Letter on November 25, 2013 and then emails CEN on November 29, 2013 asking when the site will be ready. In this letter they advise CEN that it takes an average of two weeks for the inspection once they are notified the site is ready.

CEN replies on December 7, 2013 advising the site will be ready in April, 2014. CEN accelerates the build-out at substantial cost working through the worst winter in approximately 30 years. Health Canada responds and asks for a phone call to discuss accelerating the build-out. CEN agrees to Health Canada's request and accelerates the build-out and modifies original plans to achieve the promised provisional license.

On January 2, 2014 Health Canada writes concerning the Forbes Article, CEN explains the reporter's mistake. Health Canada continues with CEN application and on January 13, 2014 asks for further information regarding site security.

On March 28, 2014 CEN notifies Health Canada of its second site and the ability to get it operational in two weeks. CEN discusses it with Health Canada via the telephone.

April 9, 2014 Health Canada surprises CEN and tells them they have to pass security clearance stage before the inspection is scheduled. They also advise it could take months. This was the first CEN heard of this requirement.

April 22, 2014 CEN notifies Health Canada that the site would be ready for inspection April 28, 2014. Health Canada acknowledges. April 29, 2014 CEN asks the status of the pre-license inspection. HC responds regarding security clearances. May 5, 2014 CEN advises of the substantial financial burden and asks when the inspection will take place. HC responds citing security clearance requirement.

May 12, 2014 CEN writes Todd Cain advising of Hardship Health Canada is causing CEN. That CEN changed the original build plans and accelerated the build-out at substantial cost at Health Canada's request. Also that CEN was aware their security clearances were conducted in August 13, 2013 and Health Canada was intentionally delaying the inspection.

CEN requests an in person meeting in Ottawa to discuss the file. Health Canada responds asking what questions did we intend to ask. CEN answers their questions on June 2, 2014

June 5, 2014 CEN is notified they passed the security clearance stage; it is no mystery what Health Canada's concerns were as they were addressed in the June 2, 2014. What is most disturbing is the alleged discrimination against a US based company.

Thank you for your attention to this important matter.

Consequently, over the next several weeks CEN Biotech will be releasing documents and allowing the public to determine for themselves what has transpired and whether the Company has been treated fairly. CEN Biotech simply asks the public to base its determination solely on the documentary evidence and not on the bashing articles that are certain to follow this release to discredit it. Thank you for your attention to this important matter.

Information Leaked

Shareholder letters 1 of 4 files

Shareholder letters 2 of 4 files

Shareholder letters 3 of 4 files

Shareholder letters 4 of 4 files

About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC PINK: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

About Creative Edge Nutrition, Inc.
Creative Edge Nutrition, Inc., is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements and energy drinks. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities.

Company Disclaimer
As a "penny stock" Company, within the meaning of federal and state securities law, Creative Edge Nutrition, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Creative Edge Nutrition, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.

Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.

Contact Information